PT35 Matching-Adjusted Indirect Comparison (MAIC) of Dabrafenib Plus Trametinib Versus Pembrolizumab Plus Chemotherapy in Patients with Treatment-Naive Metastatic BRAF V600 Mutation-Positive Non-Small Cell Lung Cancer (NSCLC)
Abstract
Authors
T.A. Tai K. Perampaladas P. Cooney L. Mensah K. Jameson R. Rafia R. Bains N. Kane